Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-06

Clinical Trial Update: BurstDR Stimulation for Painful Diabetic Neuropathy

View source ↗

Summary

A clinical trial evaluating BurstDR Stimulation for Painful Diabetic Neuropathy sponsored by Wake Forest University Health Sciences has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BurstDR Stimulation

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Painful Diabetic Neuropathy | Status: TERMINATED